Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Erosive Gastroesophageal Reflux Disease (Phase 3)
Clinical trial NCT03736369 · COMPLETED
Trial details
- NCT number
- NCT03736369
- Sponsor
- Daewoong Pharmaceutical Co. LTD.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-13
- Primary completion
- 2019-08-07
- Enrollment
- 263
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.